Oyster peptide inclusion compound as well as preparation method and application thereof
The resolvability and stability of the oyster peptide composition were solved by incorporating curcumin, puerar root extract and citrus extract with oyster peptides using methyl-β-cyclodextrin and hydroxypropyl-β-cyclodextrin. The problem of insufficient sexuality has achieved higher drug efficacy stability, antioxidant and anti-inflammatory effects, and extended the shelf life of the product.
Patent Information
- Application Number
- CN202411053009.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-11-22
AI Technical Summary
The resolvability and storage stability of existing oyster peptide compositions are insufficient, which affects its application effect in drugs and health products.
Using methyl-β-cyclodextrin and hydroxypropyl-β-cyclodextrin as inclusion materials, curcumin, pueraria root extract and citrus extract are integrated with oyster peptides to form oyster peptide inclusions. Optimize the mass ratio of the inclusion material to the total active ingredients to improve resolvency and stability.
It significantly reduces the hygroscopicity and storage stability of the inclusion compound, improves the drug effect stability, enhances the antioxidant, anti-inflammatory and hangover liver protection effects, and extends the shelf life of the product.
Smart Images

Figure CN118987157A_ABST
